Status:
RECRUITING
The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
University of Groningen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Brief Summary
Multiple Sclerosis (MS) is an invalidating neurological disease known to cause physical symptoms, which usually are the main focus of treatment. However, non-physical, more neuropsychological, symptom...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, a patient must meet all of the following criteria:
- Confirmed MS diagnosis (all subtypes);
- Age18-70;
- Adequate command of the Dutch language.
Exclusion
- Not being able to participate in a short neuropsychological assessment (NPA) as judged by the MS clinician and/or investigator;
- Presence of any other neurological and/or major psychiatric condition.
- The group of HC's will be matched to the patient group on age and education level.
Key Trial Info
Start Date :
July 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06016309
Start Date
July 20 2023
End Date
December 31 2027
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen (UMCG)
Groningen, Provincie Groningen, Netherlands, 9700 RB